NEI
Northwest & Ethical Investments Portfolio holdings
AUM
$4.03B
1-Year Return
20.27%
This Quarter Return
+4.72%
1 Year Return
+20.27%
3 Year Return
+68.59%
5 Year Return
+133.3%
10 Year Return
+253.02%
AUM
$1.48B
AUM Growth
+$23.1M
(+1.6%)
Cap. Flow
-$30.2M
Cap. Flow
% of AUM
-2.05%
Top 10 Holdings %
Top 10 Hldgs %
24.52%
Holding
411
New
34
Increased
196
Reduced
120
Closed
32
Top Buys
| 1 |
Varex Imaging
VREX
|
+$8.6M |
| 2 |
Magna International
MGA
|
+$8.5M |
| 3 |
Marathon Petroleum
MPC
|
+$5.32M |
| 4 |
Baxter International
BAX
|
+$4.2M |
| 5 |
BPY
Brookfield Property Partners L.P. Limited Partnership Units
BPY
|
+$3.99M |
Top Sells
| 1 |
Rogers Communications
RCI
|
+$17.5M |
| 2 |
POT
Potash Corp Of Saskatchewan
POT
|
+$8.24M |
| 3 |
GRP.U
Granite Real Estate Investment Trust
GRP.U
|
+$7.95M |
| 4 |
Intel
INTC
|
+$6.63M |
| 5 |
BCE
BCE
|
+$5.52M |
Sector Composition
| 1 | Financials | 25.47% |
| 2 | Industrials | 11.95% |
| 3 | Communication Services | 9.83% |
| 4 | Technology | 9.6% |
| 5 | Energy | 8.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
351
PJT Partners
PJT
$4.33B
| $91K | 0.01% |
2,593
| – | – |
|
352
HCA Healthcare
HCA
$96.8B
| $90.6K | 0.01% |
1,018
| – | – |
|
353
Labcorp
LH
$23B
| $90.2K | 0.01% |
732
+116
| +19% | +$14.3K |
|
354
Matthews International
MATW
$744M
| $86.7K | 0.01% |
1,281
| – | – |
|
355
Medtronic
MDT
$120B
| $86.4K | 0.01% |
1,073
| – | – |
|
356
General Motors
GM
$55B
| $84.9K | 0.01% |
2,400
+200
| +9% | +$7.07K |
|
357
Bank of New York Mellon
BK
$74.2B
| $81.4K | 0.01% |
1,724
-700
| -29% | -$33.1K |
|
358
JetBlue
JBLU
$1.86B
| $80.4K | 0.01% |
3,900
| – | – |
|
359
Align Technology
ALGN
$10.1B
| $80.1K | 0.01% |
698
+100
| +17% | +$11.5K |
|
360
Spectrum Brands
SPB
$1.34B
| $79.2K | 0.01% |
570
| – | – |
|
361
Zimmer Biomet
ZBH
$20.6B
| $77.7K | 0.01% |
655
+103
| +19% | +$12.2K |
|
362
Prestige Consumer Healthcare
PBH
$3.23B
| $76.8K | 0.01% |
1,382
-400
| -22% | -$22.2K |
|
|
AGN
363
DELISTED
Allergan plc
AGN
| $71.7K | ﹤0.01% |
300
| – | – |
|
364
Aflac
AFL
$57B
| $70K | ﹤0.01% |
1,934
-800
| -29% | -$29K |
|
365
Edwards Lifesciences
EW
$46.7B
| $68.2K | ﹤0.01% |
2,175
-141,600
| -98% | -$4.44M |
|
366
Incyte
INCY
$16.8B
| $66.8K | ﹤0.01% |
+500
| New | +$66.8K |
|
367
Blackrock
BLK
$171B
| $66.7K | ﹤0.01% |
174
-100
| -36% | -$38.4K |
|
368
Expedia Group
EXPE
$26.8B
| $66.6K | ﹤0.01% |
528
+100
| +23% | +$12.6K |
|
369
ResMed
RMD
$40.9B
| $66.6K | ﹤0.01% |
925
| – | – |
|
|
FRC
370
DELISTED
First Republic Bank
FRC
| $65.4K | ﹤0.01% |
697
-200
| -22% | -$18.8K |
|
371
Biogen
BIIB
$20.9B
| $64.8K | ﹤0.01% |
237
+100
| +73% | +$27.3K |
|
372
IQVIA
IQV
$32.2B
| $61.7K | ﹤0.01% |
766
| – | – |
|
373
Hilton Worldwide
HLT
$64.8B
| $55.1K | ﹤0.01% |
942
-1
| -0.1% | -$58 |
|
374
Lincoln National
LNC
$7.88B
| $52.4K | ﹤0.01% |
800
-400
| -33% | -$26.2K |
|
375
Invesco
IVZ
$9.94B
| $52.2K | ﹤0.01% |
1,704
-900
| -35% | -$27.6K |
|